Market Research Reports - Ken Research Kuwait Pharmaceuticals Market Outlook to 2022

Kuwait Pharmaceuticals Market Outlook to 2022: Ken Research
The report titled “Kuwait Pharmaceuticals Market Outlook to 2022 - By Type of Drugs
(Generic and Patented Drugs); By Channel of Distribution (Institutional Sales and Retail Sales)
and By Therapeutic Class (Anti-Infectives, Gastrointestinal, Cardiovascular, CNS, Respiratory,
Musculoskeletal, Analgesics and Anti Inflammatory and Others)” provides a comprehensive
analysis on introduction on Kuwait Pharmaceuticals market, value chain, stakeholders in
Kuwait pharmaceuticals market ecosystem, market size by revenue (2012-2017), overall
pharmaceuticals market segmentation by type of drug, by OTC and prescription drugs, by end
users, by channel of distribution and by therapeutic class, competition scenario in the industry,
shares and company profiles of major players in the market, growth drivers, trends and
developments, issues and challenges in the pharmaceuticals market and the regulatory
framework of the industry. The report also includes future outlook for the market (2018-2022)
including estimated market size in terms of revenue and pharmaceuticals market segmentation
by therapeutic class.
The report is useful for manufacturers, distributors, retailers of pharmaceuticals, hospital
chains, Drug stockiest, Healthcare IT companies to align their market centric strategies
according to ongoing and expected trends in the future.
Kuwait Pharmaceuticals Market Overview
The Kuwait Pharmaceuticals market is in the growing stage and is primarily driven by
government’s healthcare initiatives. A booming oil and gas industry and limited diversification
into other sectors have significantly constrained the manufacturing activities in Kuwait. As a
result, domestic production of medicines in the country continued to be low and majority of the
pharmaceuticals consumed were imported in this period, including branded and generic drugs.
Although the industry is closely monitored by the government, medicine prices in Kuwait
continued to be high. Doctors and patients generally prefer patented and branded products,
which has stretched the government funding system. Prevalence of chronic disorders such as
cardiovascular, diabetes, cancer and respiratory conditions was also on a rise which gave a
boost to the demand for pharmaceuticals market. The trend towards preventive healthcare
witnessed a rise in line with an increase in healthcare awareness in this period, thus supporting
expansion of the OTC segment and increasing demand for OTC medication and pseudo-
pharmaceuticals such as vitamins and supplements, weight loss formulations, and smoking
cessation aids. High public spending on healthcare and a free of cost provision of medical
services for the locals have supported demand for pharmaceuticals in the country in this period.
A number of government initiatives are also driving the pharmaceuticals market in Kuwait such
granting 12 companies medical permits to build pharmaceutical factories in collaboration with
the Public Authority for Industry (PAI) in the country, almost doubling the budget for healthcare